Reven Holdings announces first patient dosed in clinical trial evaluating RJX for high-risk COVID-19

Reven Holdings announces first patient dosed in clinical trial evaluating RJX for high-risk COVID-19

WESTMINSTER -- Reven Holdings, Inc. today announced the first patient has been dosed in the Phase I/II trial of RJX in high-risk COVID-19 patients ( ClinicalTrials.gov Identifier: NCT04708340; ... Read More

Thursday April 29, 2021 Tags: Westminster, Reven Holdings, COVID-19, Fatih Uckun, Peter Lange, Michael Volk, Brian Denomme

Flagship Biosciences and Leap Therapeutics announce partnership and approach using RNAscope and Image Analysis for patient enrollment

Flagship Biosciences and Leap Therapeutics announce partnership and approach using RNAscope and Image Analysis for patient enrollment

WESTMINSTER and CAMBRIDGE, Mass. -- Flagship Biosciences , a leader in data-centric pathology and tissue analysis, and Massachusetts-based Leap Therapeutics (Nasdaq: LPTX), a biotechnology... Read More

Wednesday April 14, 2021 Tags: Westminster, Flagship Biosciences, Leap Therapeutics, Trevor Johnson

Maxar delivers spacecraft bus for NASA’s Psyche Mission to explore asteroid

Maxar delivers spacecraft bus for NASA’s Psyche Mission to explore asteroid

WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) announced the delivery of the Solar Electric Propulsion (SEP) Chassis to NASA’s Jet Propulsion Laboratory (JPL) for the NASA Discovery... Read More

Tuesday March 30, 2021 Tags: Westminster, Maxar Technologies, Psyche, NASA, Robert Curbeam

Maxar awarded contract to support GEOINT exploitation for U.S. Army and combatant commands

Maxar awarded contract to support GEOINT exploitation for U.S. Army and combatant commands

WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) today announced it was awarded a U.S. Army contract worth as much as $48.3 million for support services in geospatial intelligence (GEOINT).... Read More

Monday March 29, 2021 Tags: Westminster, Maxar Technologies, Tony Frazier

Flagship Biosciences announces new patent

Flagship Biosciences announces new patent

WESTMINSTER -- Flagship Biosciences announced the United States Patent and Trademark Office has issued the company a new patent, No. 10,839,512, entitled “ Method of dot detection within images... Read More

Thursday February 18, 2021 Tags: Westminster, Flagship Biosciences, Trevor Johnson

Maxar Technologies appoints Heather Wilson to board of directors

Maxar Technologies appoints Heather Wilson to board of directors

WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) today announced the appointment of Dr. Heather Wilson to serve on the company’s board of directors. Wilson will serve as a director... Read More

Tuesday January 19, 2021 Tags: Westminster, Maxar Technologies, Heather Wilson, Dan Jablonsky

Cerapedics announces commercial launch of i-FACTOR®+ Matrix in Canada for surgeries

Cerapedics announces commercial launch of i-FACTOR®+ Matrix in Canada for surgeries

WESTMINSTER -- Cerapedics announced the full commercial availability of i-FACTOR+ MATRIX for surgical implantation in Canada. "We are excited to announce that i-FACTOR+ Matrix is now fully... Read More

Friday November 6, 2020 Tags: Westminster, Cerapedics, i-FACTOR+Matrix, Glen Kashuba, Jeffrey Marx

TriSalus Life Sciences lays out therapeutic strategy upon acquisition of first therapeutic candidate

TriSalus Life Sciences lays out therapeutic strategy upon acquisition of first therapeutic candidate

DENVER and CHICAGO -- TriSalus Life Sciences (TriSalus), an emerging immune-oncology company committed to transforming outcomes for patients with solid tumors, announced its therapeutic clinical... Read More

Monday September 28, 2020 Tags: Westminster, TriSalus Life Sciences, SD-101, Mats Wahlstrom, Mary Szela, Steven Katz